Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population

• मुख्य लेखकों: Erik Håkansson (लेखक), Helena Norberg (लेखक), Sara Själander (लेखक), Krister Lindmark (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Hindawi-Wiley, 2021-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Aims. This study is aimed at investigating the eligibility in a real-world heart failure population for the DAPA-HF (testing dapagliflozin) and EMPEROR-reduced (testing empagliflozin) trials, comparing the eligible real-world patients to trial participants and to characterize the noneligible patient...